Newstral
Article
jdsupra.com on 2024-04-23 22:28
CMS Changes Medicare Advantage and Part D Plans’ Agent/Broker/TPMO Compensation Landscape
Related news
- CMS Publishes Final Rule on Medicare Advantage Agent Broker Compensationjdsupra.com
- Analysis: CY 2025 Revisions to Medicare Advantage and Part D Rules Governing Agent, Broker and Third Party Compensationjdsupra.com
- Holidays Come Early as CMS Proposes to Significantly Narrow Training Requirements Under Medicare Advantage and Part D Plan Compliance Programsjdsupra.com
- CMS Proposes to Prohibit Overrides in Medicare Advantagejdsupra.com
- CMS Proposes Changes to the Medicare Advantage and Part D Programs Aimed at Improving Beneficiary Protections, Access to Care, and Addressing Agent and Broker Compensationjdsupra.com
- New CMS Rule Requires Extrapolation of Medicare Advantage RADV Audit Findingsjdsupra.com
- CMS Proposes to Expand the Scope of Medicare Coverage Determinationsjdsupra.com
- 2024 Final Rule: CMS Announces More Changes to Medicare Advantage but Declines to Reform the “60 Day Rule”jdsupra.com
- CMS Expands Medicare Advantage Telehealth Coveragejdsupra.com
- CMS Finalizes 2017 Medicare Advantage Capitation Ratesjdsupra.com
- CMS Finalizes Medicare Advantage Risk Adjustment Rulejdsupra.com
- CMS Updates Medicare Advantage RADV Programjdsupra.com
- CMS Call Letter: Medicare Advantage Contracting Considerationsjdsupra.com
- CMS Launches New Medicare Advantage Innovation Modeljdsupra.com
- CMS Finalizes General Supervision Requirement for Medicare Non-Surgical Extended Duration Therapeutic Servicesjdsupra.com
- CMS Corrects Inadvertent Omissions in Recent Stark Law Regulatory Amendments, Clarifies Reach of the Prohibition Related to Indirect Compensation Arrangementsjdsupra.com
- CMS Proposes to Reverse Course and Repeal Its Final Rule Expediting Medicare Coverage of Breakthrough Devices and Defining the Medicare “Reasonable and Necessary” Coverage Standardjdsupra.com
- CMS Proposes Basic Changes for Medicare Coverage, Including a New Reimbursement Pathway for FDA-designated Breakthrough Medical Devicesjdsupra.com
- CMS Declines to Adopt Policy Reducing Reimbursement for “Medicare” Organs for Transplant Hospitals and Organ Procurement Organizationsjdsupra.com
- CMS Preparing to Launch RACs for Medicare Advantagejdsupra.com